Did Earnings Beat, Record Sales and 2026 EPS Outlook Just Shift CVS Health's (CVS) Investment Narrative?

Simply Wall St.02-15

CVS Health recently reported fourth-quarter 2025 results showing sales of US$34.02 billion and net income of US$2.94 billion, alongside record full-year revenue of US$402.07 billion but lower annual ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2611146797?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/company-cover/93625-main-header/1756253484610","is_english":true,"pubTime":"2026-02-15 03:27","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2611146797","market":"nz","top_or_hot":-1,"title":"Did Earnings Beat, Record Sales and 2026 EPS Outlook Just Shift CVS Health's (CVS) Investment Narrative?","media":"Simply Wall St.","content":"<div>\n<p>CVS Health recently reported fourth-quarter 2025 results showing sales of US$34.02 billion and net income of US$2.94 billion, alongside record full-year revenue of US$402.07 billion but lower annual ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/did-earnings-beat-record-sales-and-2026-eps-outlook-just-shi\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Did Earnings Beat, Record Sales and 2026 EPS Outlook Just Shift CVS Health's (CVS) Investment Narrative?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDid Earnings Beat, Record Sales and 2026 EPS Outlook Just Shift CVS Health's (CVS) Investment Narrative?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-02-15 03:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/did-earnings-beat-record-sales-and-2026-eps-outlook-just-shi><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>CVS Health recently reported fourth-quarter 2025 results showing sales of US$34.02 billion and net income of US$2.94 billion, alongside record full-year revenue of US$402.07 billion but lower annual ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/did-earnings-beat-record-sales-and-2026-eps-outlook-just-shi\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CVS.AU","symbol_name":"Cervantes Corp Ltd","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/did-earnings-beat-record-sales-and-2026-eps-outlook-just-shi","article_id":"2611146797","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/company-cover/93625-main-header/1756253484610"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/did-earnings-beat-record-sales-and-2026-eps-outlook-just-shi","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2611146797","pubTimestamp":1771097233,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"CVS Health recently reported fourth-quarter 2025 results showing sales of US$34.02 billion and net income of US$2.94 billion, alongside record full-year revenue of US$402.07 billion but lower annual net income of US$1.77 billion due to goodwill and litigation charges.\nThe company also confirmed 2026 GAAP diluted EPS guidance of US$5.94–US$6.14 and highlighted progress on its cost-based pharmacy reimbursement model and Rite Aid integration as it continues its turnaround efforts.\nNow we’ll...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"CVS.AU":"Cervantes Corp Ltd","CVS":"西维斯健康"},"translate_title":"盈利超出预期、创纪录的销售额和2026年每股收益前景是否改变了CVS Health(CVS)的投资叙事？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CVS.AU":1.5,"CVS":1.5},"content_text":"CVS Health recently reported fourth-quarter 2025 results showing sales of US$34.02 billion and net income of US$2.94 billion, alongside record full-year revenue of US$402.07 billion but lower annual net income of US$1.77 billion due to goodwill and litigation charges. The company also confirmed 2026 GAAP diluted EPS guidance of US$5.94–US$6.14 and highlighted progress on its cost-based pharmacy reimbursement model and Rite Aid integration as it continues its turnaround efforts. Now we’ll examine how CVS Health’s earnings beat and reaffirmed 2026 guidance affect the existing investment narrative around its earnings recovery. Find 53 companies with promising cash flow potential yet trading below their fair value.AdvertisementCVS Health Investment Narrative RecapTo own CVS Health, I think you need to believe its integrated model can convert today’s low margins into steadier earnings across insurance, pharmacy, and care delivery. The latest quarter’s earnings beat and reaffirmed 2026 GAAP EPS guidance of US$5.94–US$6.14 support the near term earnings recovery story, while the biggest ongoing risk remains pressure on medical costs and margins in health care delivery rather than any new issue from this update. The most relevant update here is management’s confirmation of 2026 EPS guidance alongside progress on its cost based pharmacy reimbursement model. By emphasizing that the TrueCost and CostVantage approaches are now in place and aligned with recent PBM reforms, CVS is trying to stabilize a key earnings driver, which directly ties into the short term catalyst of margin recovery in Aetna and the pharmacy businesses while it absorbs prior goodwill and litigation charges. But while the turnaround is gaining traction, persistent pressure on medical benefit ratios in health care delivery is something investors should be aware of... Read the full narrative on CVS Health (it's free!)CVS Health's narrative projects $445.1 billion revenue and $8.3 billion earnings by 2028. This requires 5.0% yearly revenue growth and about a $3.8 billion earnings increase from $4.5 billion today.Uncover how CVS Health's forecasts yield a $94.76 fair value, a 21% upside to its current price.Exploring Other PerspectivesCVS 1-Year Stock Price Chart Six fair value estimates from the Simply Wall St Community span roughly US$94.76 to US$289.13, showing how far apart individual views can be. Against that wide range, the company’s need to improve thin 0.4 percent net margins and health care delivery profitability gives you a concrete set of issues to weigh as you explore those different perspectives.Explore 6 other fair value estimates on CVS Health - why the stock might be worth over 3x more than the current price!Build Your Own CVS Health NarrativeDisagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.A great starting point for your CVS Health research is our analysis highlighting 3 key rewards and 4 important warning signs that could impact your investment decision.Our free CVS Health research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate CVS Health's overall financial health at a glance.Ready For A Different Approach?Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:Outshine the giants: these 28 early-stage AI stocks could fund your retirement.Invest in the nuclear renaissance through our list of 85 elite nuclear energy infrastructure plays powering the global AI revolution.Explore 23 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2611146797","isCrawlerRequest":true}